S&P 500   3,811.15
DOW   30,932.37
QQQ   314.14
pixel
pixel
S&P 500   3,811.15
DOW   30,932.37
QQQ   314.14
pixel
pixel
S&P 500   3,811.15
DOW   30,932.37
QQQ   314.14
pixel
pixel
S&P 500   3,811.15
DOW   30,932.37
QQQ   314.14
pixel
pixel
Log in
ETR:HNL

Dr. Hönle AG (HNL.F) Competitors

€44.35
-0.20 (-0.45 %)
(As of 02/26/2021 12:00 AM ET)
Add
Compare
Today's Range
€43.10
Now: €44.35
€45.90
50-Day Range
€44.55
MA: €53.09
€56.30
52-Week Range
€24.45
Now: €44.35
€60.40
Volume22,382 shs
Average VolumeN/A
Market Capitalization$268.84 million
P/E Ratio52.61
Dividend Yield1.05%
BetaN/A

Competitors

Dr. Hönle AG (HNL.F) (ETR:HNL) Vs. ISR, ADV, GFT, M5Z, HOC, and WDI

Should you be buying HNL stock or one of its competitors? Companies in the sector of "computer and technology" are considered alternatives and competitors to Dr. Hönle AG (HNL.F), including Isra Vision (ISR), ADVA Optical Networking (ADV), GFT Technologies (GFT), Manz (M5Z), HolidayCheck Group (HOC), and Wirecard (WDI).

Isra Vision (ETR:ISR) and Dr. Hönle AG (HNL.F) (ETR:HNL) are both small-cap computer and technology companies, but which is the better stock? We will compare the two companies based on the strength of their risk, dividends, institutional ownership, earnings, analyst recommendations, profitability and valuation.

Profitability

This table compares Isra Vision and Dr. Hönle AG (HNL.F)'s net margins, return on equity and return on assets.

Net MarginsReturn on EquityReturn on Assets
Isra VisionN/AN/AN/A
Dr. Hönle AG (HNL.F)N/AN/AN/A

Valuation and Earnings

This table compares Isra Vision and Dr. Hönle AG (HNL.F)'s top-line revenue, earnings per share and valuation.

Gross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Isra Vision$129.31 million8.01$9.43 million€0.43109.74
Dr. Hönle AG (HNL.F)$95.34 million2.82$5.11 million€0.8452.61

Isra Vision has higher revenue and earnings than Dr. Hönle AG (HNL.F). Dr. Hönle AG (HNL.F) is trading at a lower price-to-earnings ratio than Isra Vision, indicating that it is currently the more affordable of the two stocks.

Analyst Ratings

This is a summary of current ratings for Isra Vision and Dr. Hönle AG (HNL.F), as reported by MarketBeat.

Sell RatingsHold RatingsBuy RatingsStrong Buy RatingsRating Score
Isra Vision10001.00
Dr. Hönle AG (HNL.F)00203.00

Isra Vision currently has a consensus price target of €50.00, indicating a potential upside of 5.71%. Dr. Hönle AG (HNL.F) has a consensus price target of €66.75, indicating a potential upside of 50.51%. Given Dr. Hönle AG (HNL.F)'s stronger consensus rating and higher probable upside, analysts plainly believe Dr. Hönle AG (HNL.F) is more favorable than Isra Vision.

Dividends

Isra Vision pays an annual dividend of €0.18 per share and has a dividend yield of 0.4%. Dr. Hönle AG (HNL.F) pays an annual dividend of €0.50 per share and has a dividend yield of 1.1%. Isra Vision pays out 41.8% of its earnings in the form of a dividend. Dr. Hönle AG (HNL.F) pays out 59.3% of its earnings in the form of a dividend. Both companies have healthy payout ratios and should be able to cover their dividend payments with earnings for the next several years.

Dr. Hönle AG (HNL.F) (ETR:HNL) and ADVA Optical Networking (ETR:ADV) are both small-cap computer and technology companies, but which is the superior business? We will compare the two businesses based on the strength of their valuation, profitability, earnings, dividends, institutional ownership, analyst recommendations and risk.

Analyst Ratings

This is a breakdown of current ratings and target prices for Dr. Hönle AG (HNL.F) and ADVA Optical Networking, as provided by MarketBeat.

Sell RatingsHold RatingsBuy RatingsStrong Buy RatingsRating Score
Dr. Hönle AG (HNL.F)00203.00
ADVA Optical Networking01102.50

Dr. Hönle AG (HNL.F) currently has a consensus target price of €66.75, indicating a potential upside of 50.51%. ADVA Optical Networking has a consensus target price of €8.38, indicating a potential downside of 8.27%. Given Dr. Hönle AG (HNL.F)'s stronger consensus rating and higher probable upside, equities research analysts clearly believe Dr. Hönle AG (HNL.F) is more favorable than ADVA Optical Networking.

Profitability

This table compares Dr. Hönle AG (HNL.F) and ADVA Optical Networking's net margins, return on equity and return on assets.

Net MarginsReturn on EquityReturn on Assets
Dr. Hönle AG (HNL.F)N/AN/AN/A
ADVA Optical NetworkingN/AN/AN/A

Valuation & Earnings

This table compares Dr. Hönle AG (HNL.F) and ADVA Optical Networking's gross revenue, earnings per share (EPS) and valuation.

Gross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Dr. Hönle AG (HNL.F)$95.34 million2.82$5.11 million€0.8452.61
ADVA Optical Networking$575.52 million0.80$9.54 million€0.1948.05

ADVA Optical Networking has higher revenue and earnings than Dr. Hönle AG (HNL.F). ADVA Optical Networking is trading at a lower price-to-earnings ratio than Dr. Hönle AG (HNL.F), indicating that it is currently the more affordable of the two stocks.

Summary

Dr. Hönle AG (HNL.F) beats ADVA Optical Networking on 6 of the 8 factors compared between the two stocks.

GFT Technologies (ETR:GFT) and Dr. Hönle AG (HNL.F) (ETR:HNL) are both small-cap computer and technology companies, but which is the superior business? We will contrast the two companies based on the strength of their risk, dividends, profitability, valuation, institutional ownership, earnings and analyst recommendations.

Valuation and Earnings

This table compares GFT Technologies and Dr. Hönle AG (HNL.F)'s revenue, earnings per share (EPS) and valuation.

Gross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
GFT Technologies$440.23 million0.94$9.95 million€0.3841.69
Dr. Hönle AG (HNL.F)$95.34 million2.82$5.11 million€0.8452.61

GFT Technologies has higher revenue and earnings than Dr. Hönle AG (HNL.F). GFT Technologies is trading at a lower price-to-earnings ratio than Dr. Hönle AG (HNL.F), indicating that it is currently the more affordable of the two stocks.

Analyst Recommendations

This is a breakdown of current recommendations and price targets for GFT Technologies and Dr. Hönle AG (HNL.F), as reported by MarketBeat.

Sell RatingsHold RatingsBuy RatingsStrong Buy RatingsRating Score
GFT Technologies00103.00
Dr. Hönle AG (HNL.F)00203.00

GFT Technologies currently has a consensus price target of €14.50, suggesting a potential downside of 7.99%. Dr. Hönle AG (HNL.F) has a consensus price target of €66.75, suggesting a potential upside of 50.51%. Given Dr. Hönle AG (HNL.F)'s higher possible upside, analysts plainly believe Dr. Hönle AG (HNL.F) is more favorable than GFT Technologies.

Dividends

GFT Technologies pays an annual dividend of €0.20 per share and has a dividend yield of 1.3%. Dr. Hönle AG (HNL.F) pays an annual dividend of €0.50 per share and has a dividend yield of 1.1%. GFT Technologies pays out 52.9% of its earnings in the form of a dividend. Dr. Hönle AG (HNL.F) pays out 59.3% of its earnings in the form of a dividend. Both companies have healthy payout ratios and should be able to cover their dividend payments with earnings for the next several years. GFT Technologies is clearly the better dividend stock, given its higher yield and lower payout ratio.

Profitability

This table compares GFT Technologies and Dr. Hönle AG (HNL.F)'s net margins, return on equity and return on assets.

Net MarginsReturn on EquityReturn on Assets
GFT TechnologiesN/AN/AN/A
Dr. Hönle AG (HNL.F)N/AN/AN/A

Summary

Dr. Hönle AG (HNL.F) beats GFT Technologies on 5 of the 9 factors compared between the two stocks.

Manz (ETR:M5Z) and Dr. Hönle AG (HNL.F) (ETR:HNL) are both small-cap computer and technology companies, but which is the better business? We will contrast the two businesses based on the strength of their risk, valuation, analyst recommendations, dividends, institutional ownership, profitability and earnings.

Profitability

This table compares Manz and Dr. Hönle AG (HNL.F)'s net margins, return on equity and return on assets.

Net MarginsReturn on EquityReturn on Assets
ManzN/AN/AN/A
Dr. Hönle AG (HNL.F)N/AN/AN/A

Valuation and Earnings

This table compares Manz and Dr. Hönle AG (HNL.F)'s revenue, earnings per share and valuation.

Gross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Manz$244.16 million1.49$4.20 million€0.5486.53
Dr. Hönle AG (HNL.F)$95.34 million2.82$5.11 million€0.8452.61

Dr. Hönle AG (HNL.F) has lower revenue, but higher earnings than Manz. Dr. Hönle AG (HNL.F) is trading at a lower price-to-earnings ratio than Manz, indicating that it is currently the more affordable of the two stocks.

Analyst Ratings

This is a breakdown of current recommendations for Manz and Dr. Hönle AG (HNL.F), as reported by MarketBeat.com.

Sell RatingsHold RatingsBuy RatingsStrong Buy RatingsRating Score
Manz0000N/A
Dr. Hönle AG (HNL.F)00203.00

Dr. Hönle AG (HNL.F) has a consensus target price of €66.75, suggesting a potential upside of 50.51%. Given Dr. Hönle AG (HNL.F)'s higher possible upside, analysts clearly believe Dr. Hönle AG (HNL.F) is more favorable than Manz.

Summary

Dr. Hönle AG (HNL.F) beats Manz on 5 of the 7 factors compared between the two stocks.

Dr. Hönle AG (HNL.F) (ETR:HNL) and HolidayCheck Group (ETR:HOC) are both small-cap computer and technology companies, but which is the superior investment? We will compare the two businesses based on the strength of their valuation, risk, analyst recommendations, dividends, earnings, profitability and institutional ownership.

Profitability

This table compares Dr. Hönle AG (HNL.F) and HolidayCheck Group's net margins, return on equity and return on assets.

Net MarginsReturn on EquityReturn on Assets
Dr. Hönle AG (HNL.F)N/AN/AN/A
HolidayCheck GroupN/AN/AN/A

Earnings and Valuation

This table compares Dr. Hönle AG (HNL.F) and HolidayCheck Group's revenue, earnings per share and valuation.

Gross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Dr. Hönle AG (HNL.F)$95.34 million2.82$5.11 million€0.8452.61
HolidayCheck Group$53.72 million3.58$-102,777,720.00(€1.18)-1.87

Dr. Hönle AG (HNL.F) has higher revenue and earnings than HolidayCheck Group. HolidayCheck Group is trading at a lower price-to-earnings ratio than Dr. Hönle AG (HNL.F), indicating that it is currently the more affordable of the two stocks.

Analyst Ratings

This is a summary of current ratings and target prices for Dr. Hönle AG (HNL.F) and HolidayCheck Group, as reported by MarketBeat.

Sell RatingsHold RatingsBuy RatingsStrong Buy RatingsRating Score
Dr. Hönle AG (HNL.F)00203.00
HolidayCheck Group0000N/A

Dr. Hönle AG (HNL.F) currently has a consensus price target of €66.75, indicating a potential upside of 50.51%. Given Dr. Hönle AG (HNL.F)'s higher probable upside, analysts plainly believe Dr. Hönle AG (HNL.F) is more favorable than HolidayCheck Group.

Dividends

Dr. Hönle AG (HNL.F) pays an annual dividend of €0.50 per share and has a dividend yield of 1.1%. HolidayCheck Group pays an annual dividend of €0.04 per share and has a dividend yield of 1.8%. Dr. Hönle AG (HNL.F) pays out 59.3% of its earnings in the form of a dividend. HolidayCheck Group pays out -3.4% of its earnings in the form of a dividend. Both companies have healthy payout ratios and should be able to cover their dividend payments with earnings for the next several years. HolidayCheck Group is clearly the better dividend stock, given its higher yield and lower payout ratio.

Summary

Dr. Hönle AG (HNL.F) beats HolidayCheck Group on 6 of the 9 factors compared between the two stocks.

Wirecard (ETR:WDI) and Dr. Hönle AG (HNL.F) (ETR:HNL) are both small-cap computer and technology companies, but which is the superior investment? We will compare the two businesses based on the strength of their profitability, risk, institutional ownership, earnings, dividends, analyst recommendations and valuation.

Profitability

This table compares Wirecard and Dr. Hönle AG (HNL.F)'s net margins, return on equity and return on assets.

Net MarginsReturn on EquityReturn on Assets
WirecardN/AN/AN/A
Dr. Hönle AG (HNL.F)N/AN/AN/A

Valuation and Earnings

This table compares Wirecard and Dr. Hönle AG (HNL.F)'s revenue, earnings per share and valuation.

Gross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Wirecard$2.58 billion0.02$481.54 million€3.900.11
Dr. Hönle AG (HNL.F)$95.34 million2.82$5.11 million€0.8452.61

Wirecard has higher revenue and earnings than Dr. Hönle AG (HNL.F). Wirecard is trading at a lower price-to-earnings ratio than Dr. Hönle AG (HNL.F), indicating that it is currently the more affordable of the two stocks.

Dividends

Wirecard pays an annual dividend of €0.20 per share and has a dividend yield of 48.7%. Dr. Hönle AG (HNL.F) pays an annual dividend of €0.50 per share and has a dividend yield of 1.1%. Wirecard pays out 5.1% of its earnings in the form of a dividend. Dr. Hönle AG (HNL.F) pays out 59.3% of its earnings in the form of a dividend. Both companies have healthy payout ratios and should be able to cover their dividend payments with earnings for the next several years. Wirecard is clearly the better dividend stock, given its higher yield and lower payout ratio.

Analyst Ratings

This is a summary of current recommendations and price targets for Wirecard and Dr. Hönle AG (HNL.F), as reported by MarketBeat.com.

Sell RatingsHold RatingsBuy RatingsStrong Buy RatingsRating Score
Wirecard35602.21
Dr. Hönle AG (HNL.F)00203.00

Wirecard currently has a consensus target price of €152.07, suggesting a potential upside of 36,909.35%. Dr. Hönle AG (HNL.F) has a consensus target price of €66.75, suggesting a potential upside of 50.51%. Given Wirecard's higher possible upside, research analysts clearly believe Wirecard is more favorable than Dr. Hönle AG (HNL.F).

Summary

Wirecard beats Dr. Hönle AG (HNL.F) on 7 of the 10 factors compared between the two stocks.


Dr. Hönle AG (HNL.F) Competitors List

Competitor NameCompetitor BTM RankCompetitor PriceCompetitor Price ChangeCompetitor Market CapCompetitor RevenueCompetitor P/E RatioCompetitor Indicator(s)
Isra Vision logo
ISR
Isra Vision
0.7$47.30-0.0%$1.04 billion$129.31 million109.74Upcoming Earnings
High Trading Volume
ADVA Optical Networking logo
ADV
ADVA Optical Networking
0.8$9.13-0.8%$458.22 million$575.52 million48.05News Coverage
GFT Technologies logo
GFT
GFT Technologies
1.1$15.76-1.8%$414.96 million$440.23 million41.69News Coverage
M5Z
Manz
0.5$46.90-1.7%$363.20 million$244.16 million86.53High Trading Volume
HOC
HolidayCheck Group
0.7$2.20-1.4%$192.44 million$53.72 million-1.87High Trading Volume
Gap Up
Wirecard logo
WDI
Wirecard
1.9$0.41-2.4%$50.77 million$2.58 billion0.11News Coverage
Gap Up
SYV
3D Systems
0.6$9.22-0.0%$0.00N/A0.00High Trading Volume
OU1
Absolute Software Co. (OU1.F)
0.4N/AN/A$0.00N/A0.00High Trading Volume
Gap Down
Capgemini logo
CAP
Capgemini
0.7$133.15-0.6%$0.00N/A0.00News Coverage
Infineon Technologies AG (IFXA.F) logo
IFXA
Infineon Technologies AG (IFXA.F)
1.5N/AN/A$0.00N/A0.00Analyst Report
OSRAM Licht logo
OSR
OSRAM Licht
0.6$51.28-0.1%$0.00N/A0.00High Trading Volume
Proximus logo
PROX
Proximus
0.4N/AN/A$0.00N/A0.00Gap Down
Prysmian logo
PRY
Prysmian
0.7N/AN/A$0.00N/A0.00News Coverage
Gap Down
REY
Reply S.p.A. (REY.MI)
0.5N/AN/A$0.00N/A0.00
Rocket Internet logo
RKET
Rocket Internet
0.9$23.94-0.3%$0.00N/A0.00High Trading Volume
Rogers logo
ROG
Rogers
1.5N/AN/A$0.00N/A0.00Analyst Report
Gap Down
Siltronic logo
WAF
Siltronic
0.8$138.35-0.1%$0.00N/A0.00Analyst Report
High Trading Volume
STMicroelectronics logo
STM
STMicroelectronics
1.1$31.97-1.4%$0.00N/A0.00Analyst Report
High Trading Volume
News Coverage
Vivendi SA (VIV.PA) logo
VIV
Vivendi SA (VIV.PA)
1.1$28.57-1.4%$0.00N/A0.00
This page was last updated on 2/28/2021 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.